Safety Assessment

Comprehensive, GLP-compliant services to support discovery programs, IND and NDA filings with FDA, EMA and CFDA

Pharmaron’s experienced team evaluates the safety of new drug candidates from general toxicology, safety pharmacology, genetic toxicology, DART to immunotoxicity and immunogenicity in support of our partner’s IND and NDA submissions worldwide.

Pharmaron’s safety assessment facilities are AAALAC-accredited and have successfully passed worldwide regulatory inspections. This includes three US FDA inspections since 2009, GLP certification from the Belgium GLP Authority since 2017 and GLP certification from China’s NMPA since 2014.